Replicate Bioscience Announces Publication of Promising New Phase 1 Durability Data for Its srRNA Vaccine Candidate RBI-4000
By SquaredTown on September 24, 2025
Eight month follow-up data published in Communications Medicine, a Nature portfolio journal Full clinical dataset supports further development of RBI-4000 as a next generation vaccine approach for rabies, an ongoing global public health concern Optimized RNA vaccine demonstrates ability...